Pillar guide — primary care transformation
Primary care transformation.
Why transformation needs pharmacy capacity
Clinical pharmacy is the single biggest enabler of PCN-scale delivery.
Every major Primary Care Network deliverable — SMRs, Enhanced Health in Care Homes, Anticipatory Care, CVD prevention, IIF medicines-safety indicators, QOF LTC clinics — depends on clinical pharmacy capacity. No other ARRS role has the same breadth of fit across the DES, IIF and QOF.
The structural problem is not the business case — it is converting ARRS allocation into a working, supervised, retained team that actually delivers. BCS solves that with a dual-hub managed model: Halifax (West Yorkshire) for the North and Midlands, Chiswick (West London) for the South, with shared SOPs, supervision and same-week cross-cover. We are the only UK provider running this setup.
What we deliver
Primary care transformation, operationalised.
- PCN DES 2026/27 specification delivery (SMR, EHCH, Anticipatory Care, CVD)
- ARRS workforce strategy and mobilisation
- IIF and QOF medicines-related delivery
- Care home pathway transformation
- CVD prevention case-finding and titration
- Integrated neighbourhood team pharmacy input
What good looks like
Outcomes at PCN scale.
Primary care transformation FAQ.
What is meant by primary care transformation?+
The shift from reactive single-practice GP work to a Primary Care Network model — multidisciplinary teams, DES service specifications, ARRS-funded roles, IIF and QOF income, care home and frailty pathways, anticipatory care and integrated neighbourhood teams. Clinical pharmacy capacity is the single most-cited enabler of effective PCN-scale delivery.
Which DES specifications are highest priority for 2026/27?+
SMR, Enhanced Health in Care Homes (EHCH) and Anticipatory Care carry the largest evidence requirement. CVD prevention is increasingly woven across DES, IIF and QOF. ARRS audit is tightening on supervision and clinical activity evidence.
How does ARRS workforce strategy fit primary care transformation?+
ARRS funds the multidisciplinary team — clinical pharmacist, technician, nursing associate, social prescriber and more. The PCNs that get the most from transformation treat ARRS as a coherent workforce strategy, not a series of one-off hires.
What is IIF and how is it earned?+
The Investment and Impact Fund pays PCNs for delivery on a defined set of indicators — many medicines-safety, antimicrobial stewardship and LTC indicators that clinical pharmacy capacity directly delivers. Pharmacist-led work protects this income line.
Can BCS support ICB-wide primary care transformation?+
Yes — BCS is already commissioned at place level in NHS West Yorkshire ICB and mobilising in NHS NW London and NHS NCL ICBs. The dual-hub model is the only UK provider setup capable of consistent ICB-scale delivery across North and South.
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.